250 related articles for article (PubMed ID: 18570608)
1. Moxifloxacin: a respiratory fluoroquinolone.
Miravitlles M; Anzueto A
Expert Opin Pharmacother; 2008 Jul; 9(10):1755-72. PubMed ID: 18570608
[TBL] [Abstract][Full Text] [Related]
2. Moxifloxacin in respiratory tract infections.
Miravitlles M
Expert Opin Pharmacother; 2005 Feb; 6(2):283-93. PubMed ID: 15757424
[TBL] [Abstract][Full Text] [Related]
3. A pharmacoeconomic review of the management of respiratory tract infections with moxifloxacin.
Simoens S; Decramer M
Expert Opin Pharmacother; 2008 Jul; 9(10):1735-44. PubMed ID: 18570606
[TBL] [Abstract][Full Text] [Related]
4. Moxifloxacin: a review of its use in the management of bacterial infections.
Keating GM; Scott LJ
Drugs; 2004; 64(20):2347-77. PubMed ID: 15456331
[TBL] [Abstract][Full Text] [Related]
5. Moxifloxacin: a review of its clinical potential in the management of community-acquired respiratory tract infections.
Balfour JA; Lamb HM
Drugs; 2000 Jan; 59(1):115-39. PubMed ID: 10718103
[TBL] [Abstract][Full Text] [Related]
6. Fluoroquinolones in the management of community-acquired pneumonia in primary care.
Wispelwey B; Schafer KR
Expert Rev Anti Infect Ther; 2010 Nov; 8(11):1259-71. PubMed ID: 21073291
[TBL] [Abstract][Full Text] [Related]
7. Moxifloxacin in the management of exacerbations of chronic bronchitis and COPD.
Miravitlles M
Int J Chron Obstruct Pulmon Dis; 2007; 2(3):191-204. PubMed ID: 18229559
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of moxifloxacin for community-acquired bacterial pneumonia based on pharmacokinetic analysis.
Yoshida K; Okimoto N; Kishimoto M; Fukano H; Hara H; Yoneyama H; Moriya O; Kawanishi M; Kimura M; Matsushima T; Niki Y
J Infect Chemother; 2011 Oct; 17(5):678-85. PubMed ID: 21847518
[TBL] [Abstract][Full Text] [Related]
9. Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study: microbiology from the medical office practice environment.
Pfaller MA; Ehrhardt AF; Jones RN
Am J Med; 2001 Dec; 111 Suppl 9A():4S-12S; discussion 36S-38S. PubMed ID: 11755437
[TBL] [Abstract][Full Text] [Related]
10. Moxifloxacin (Avelox): an 8-methoxyquinolone antibacterial with enhanced potency.
Ball P
Int J Clin Pract; 2000 Jun; 54(5):329-32. PubMed ID: 10954961
[TBL] [Abstract][Full Text] [Related]
11. Doxycycline or moxifloxacin for the management of community-acquired pneumonia in the UK?
Ludlam HA; Enoch DA
Int J Antimicrob Agents; 2008 Aug; 32(2):101-5. PubMed ID: 18571380
[TBL] [Abstract][Full Text] [Related]
12. Moxifloxacin (Avelox): a novel fluoroquinolone with a broad spectrum of activity.
Caeiro JP; Iannini PB
Expert Rev Anti Infect Ther; 2003 Oct; 1(3):363-70. PubMed ID: 15482134
[TBL] [Abstract][Full Text] [Related]
13. Clinical perspectives on new antimicrobials: focus on fluoroquinolones.
Talan DA
Clin Infect Dis; 2001 Mar; 32 Suppl 1():S64-71. PubMed ID: 11249831
[TBL] [Abstract][Full Text] [Related]
14. [A comparison of moxifloxacin and amoxicillin in the treatment of community-acquired pneumonia in Latin America: results of a multicenter clinical trial].
Jardim JR; Rico G; de la Roza C; Obispo E; Urueta J; Wolff M; Miravitlles M;
Arch Bronconeumol; 2003 Sep; 39(9):387-93. PubMed ID: 12975069
[TBL] [Abstract][Full Text] [Related]
15. [Moxifloxacin, a novel extended spectrum fluoroquinolone in the treatment of severe infectious inflammatory diseases].
Svetukhin AM; Blatun LA; Ukhin SA
Antibiot Khimioter; 2005; 50(2-3):64-72. PubMed ID: 16308942
[No Abstract] [Full Text] [Related]
16. [New fluoroquinolones: levofloxacin, moxifloxacin and gatifloxacin].
Hoepelman I
Ned Tijdschr Geneeskd; 2004 Oct; 148(43):2115-21. PubMed ID: 15553354
[TBL] [Abstract][Full Text] [Related]
17. Moxifloxacin--a new fluoroquinolone antibacterial.
Drug Ther Bull; 2004 Aug; 42(8):61-2. PubMed ID: 15310155
[TBL] [Abstract][Full Text] [Related]
18. A brief review of moxifloxacin in the treatment of elderly patients with community-acquired pneumonia (CAP).
Ferrara AM
Clin Interv Aging; 2007; 2(2):179-87. PubMed ID: 18044134
[TBL] [Abstract][Full Text] [Related]
19. Treatment of community-acquired pneumonia with moxifloxacin: a meta-analysis of randomized controlled trials.
Yuan X; Liang BB; Wang R; Liu YN; Sun CG; Cai Y; Yu XH; Bai N; Zhao TM; Cui JC; Chen LA
J Chemother; 2012 Oct; 24(5):257-67. PubMed ID: 23182045
[TBL] [Abstract][Full Text] [Related]
20. [Role of moxifloxacin in the treatment of community-acquired pneumonia].
Máthé A; Tóth K; Kovács G
Orv Hetil; 2004 Oct; 145(44):2227-30. PubMed ID: 15626167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
